<div id="readability-page-1"><p>Avantor, Inc. (NYSE:AVTR - Get Free Report)'s share price gapped up prior to trading on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $7.86, but opened at $8.50. Avantor shares last traded at $7.92, with a volume of 2,179,825 shares trading hands.</p><p>The company reported $0.17 earnings per share for the quarter, topping analysts' consensus estimates of $0.16 by $0.01. The firm had revenue of $1.58 billion during the quarter, compared to analysts' expectations of $1.55 billion. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. The firm's revenue was up .0% on a year-over-year basis. During the same period in the prior year, the company earned $0.23 EPS. </p><h2>Wall Street Analyst Weigh In</h2><p>Several analysts have recently weighed in on AVTR shares. Robert W. Baird  set a $11.00 target price on Avantor in a research note on Thursday, February 12th. Zacks Research cut Avantor from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a research note on Friday, February 13th. Jefferies Financial Group  restated an &#34;underperform&#34; rating and set a $8.00 price objective on shares of Avantor in a research note on Thursday, February 12th. Morgan Stanley  set a $10.00 price objective on Avantor in a report on Friday, February 13th. Finally, Barclays cut their target price on Avantor from $8.50 to $7.00 and set an &#34;underweight&#34; rating on the stock in a research report on Tuesday, April 14th. Three analysts have rated the stock with a Buy rating, nine have assigned  a Hold rating and three have issued  a Sell rating to the company's stock. According to MarketBeat.com, Avantor presently has an average rating of &#34;Hold&#34; and a consensus price target of $11.54.</p><p><b>Read Our Latest Stock Analysis on AVTR</b></p><h2>Insider Activity at Avantor</h2><p>In related news, Director Sanjeev K. Mehra bought 125,000 shares of the company's stock in a transaction on Tuesday, March 10th. The shares were purchased at an average cost of $8.01 per share, with a total value of $1,001,250.00. Following the completion of the transaction, the director directly owned 475,000 shares of the company's stock, valued at approximately $3,804,750. This represents a 35.71% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Gregory L. Summe purchased 100,000 shares of Avantor stock in a transaction dated Thursday, February 12th. The shares were purchased at an average cost of $9.40 per share, with a total value of $940,000.00. Following the acquisition, the director owned 400,000 shares of the company's stock, valued at approximately $3,760,000. This trade represents a 33.33% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased 275,000 shares of company stock worth $2,399,250 in the last 90 days. 0.28% of the stock is currently owned by company insiders. </p><h2>Institutional Inflows and Outflows</h2><p>Several institutional investors and hedge funds have recently bought and sold shares of the company. Wellington Management Group LLP bought a new stake in shares of  Avantor during the fourth quarter valued at approximately $268,584,000.  Greenhaven Associates Inc. bought a new position in  Avantor in the 3rd quarter worth approximately $228,528,000.  London Co. of Virginia acquired a new stake in  Avantor in the 3rd quarter valued at approximately $159,669,000.  Morgan Stanley increased its position in  Avantor by 179.4% in the 4th quarter. Morgan Stanley now owns 17,468,418 shares of the company's stock valued at $200,188,000 after acquiring an additional 11,216,565 shares during the period.  Finally, Norges Bank bought a new stake in  Avantor during the 4th quarter valued at $73,322,000. Institutional investors own  95.08% of the company's stock. </p><h2>Avantor Stock Down 0.4%</h2><p>The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.18 and a current ratio of 1.78. The firm has a 50 day simple moving average of $8.19 and a two-hundred day simple moving average of $10.53. The stock has a market cap of $5.34 billion, a P/E ratio of -10.00, a P/E/G ratio of 3.13 and a beta of 1.00. </p><h2>About Avantor</h2> (Get Free Report)<p>Avantor, Inc <span>NYSE: AVTR<span></span></span> is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education &amp; government, and advanced technologies &amp; applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.  </p><p>Avantor's offerings are organized across two primary segments.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Avantor</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Avantor Right Now?</h2><p>Before you consider Avantor, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.</p><p>While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

AVTR

<p>Avantor, Inc. (NYSE:AVTR) shares gapped up to $8.50 after reporting better-than-expected quarterly earnings of $0.17 per share, surpassing estimates of $0.16. The company also reported revenue of $1.58 billion, exceeding expectations of $1.55 billion. Analysts have mixed ratings on the stock, with a consensus price target of $11.54. Recent insider purchases indicate confidence in the company, while institutional investors hold 95.08% of the stock. Despite the positive earnings, the stock is down 0.4% with a market cap of $5.34 billion.</p>

Market Beat

Avantor

First Trust NYSE Arca Biotech Index Fd

VanEck Biotech ETF

iShares US Medical Devices

Direxion S&P Biotech Bull 3X

Proshares Ultra Nasdaq Biotech

Invesco Biotechnology & Genome ETF

SPDR S&P Health Equip

SPDR S&P Biotech

iShares Biotechnology ETF

ALPS Medical Breakthrough

Jefferies Financial

Morgan Stanley

Barclays

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

Avantor (NYSE:AVTR) Shares Gap Up  on Strong Earnings